KROS240621P00035000 Option on Keros TherapeuticsInc
| KROS Stock | USD 46.87 0.56 1.21% |
Keros TherapeuticsInc's option chain provides insight into all available option contracts written on Keros TherapeuticsInc's stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of Keros TherapeuticsInc's stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given Keros option contract.
In The Money vs. Out of Money Option Contracts on Keros TherapeuticsInc
Analyzing Keros TherapeuticsInc's in-the-money options over time can help investors to take a profitable long position in Keros TherapeuticsInc regardless of its overall volatility. This is especially true when Keros TherapeuticsInc's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Keros TherapeuticsInc's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Keros TherapeuticsInc's stock while costing only a fraction of its price.
Keros TherapeuticsInc's latest option contracts expiring on 2024-06-21 are carrying combined implied volatility of 121.53 with a put-to-call open interest ratio of 0.92 over 42 outstanding agreements suggesting investors are buying slightly more calls than puts on contracts expiring on 2024-06-21. The current put volume is at 2, with calls trading at the volume of 1. This yields a 2.0 put-to-call volume ratio. The Keros TherapeuticsInc option chain provides detailed quote and price information for the current Keros TherapeuticsInc option contracts. It shows all of Keros TherapeuticsInc's listed puts, calls, expiration dates, strike prices, and other pricing information.
Open Interest Against 2024-06-21 Option Contracts
Keros TherapeuticsInc option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Keros TherapeuticsInc's lending market. For example, when Keros TherapeuticsInc's puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Keros TherapeuticsInc, he or she must hedge the risk by shorting Keros TherapeuticsInc stock over its option's life.
2024-06-21
The chart above shows Keros TherapeuticsInc's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Keros TherapeuticsInc's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Keros TherapeuticsInc's option, there is no secondary market available for investors to trade.
Keros TherapeuticsInc Maximum Pain Price across 2024-06-21 Option Contracts
Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Keros TherapeuticsInc close to expiration to expire worthless. According to most research, approximately 10% to 15% of all stock options are exercised, while about 35% expire worthlessly, with roughly 50% traded out before the expiration date. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthless.
Keros TherapeuticsInc's stock options are financial instruments that give investors the right to buy or sell shares of Keros TherapeuticsInc common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Keros stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Keros TherapeuticsInc's stock price goes up or down, the stock options follow.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Keros TherapeuticsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. Please note that buying 'in-the-money' options on Keros TherapeuticsInc lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Keros TherapeuticsInc's value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Keros TherapeuticsInc contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Keros Stock moves the wrong way.
At this time, Keros TherapeuticsInc's Other Stockholder Equity is comparatively stable compared to the past year. Stock Based Compensation is likely to gain to about 30.2 M in 2024, whereas Common Stock Total Equity is likely to drop 1,980 in 2024. Keros TherapeuticsInc In The Money Call Balance
When Keros TherapeuticsInc's strike price is surpassing the current stock price, the option contract against Keros TherapeuticsInc stock is said to be in the money. When it comes to buying Keros TherapeuticsInc's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Keros TherapeuticsInc are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Keros Current Options Market Mood
Keros TherapeuticsInc's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Keros Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Most options investors, including buyers and sellers of Keros TherapeuticsInc's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Keros TherapeuticsInc's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Keros TherapeuticsInc's option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.
Rule 16 of the current Keros contract
Base on the Rule 16, the options market is currently suggesting that Keros TherapeuticsInc will have an average daily up or down price movement of about 7.6% per day over the life of the 2024-06-21 option contract. With Keros TherapeuticsInc trading at USD 46.87, that is roughly USD 3.56. If you think that the market is fully incorporating Keros TherapeuticsInc's daily price movement you should consider buying Keros TherapeuticsInc options at the current volatility level of 121.53%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Keros |
Purchasing Keros TherapeuticsInc options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Keros calls. Remember, the seller must deliver Keros TherapeuticsInc stock to the call owner when a call is exercised.
Keros TherapeuticsInc Option Chain
When Keros TherapeuticsInc's strike price is surpassing the current stock price, the option contract against Keros TherapeuticsInc stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Keros TherapeuticsInc's option chain is a display of a range of information that helps investors for ways to trade options on Keros. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Keros. It also shows strike prices and maturity days for a Keros TherapeuticsInc against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Call | 2024-06-21 CALL at $15.0 | 0.9956 | 6.0E-4 | 0 | 2024-06-21 | 29.5 - 34.4 | 0.0 | In |
Call | 2024-06-21 CALL at $17.5 | 0.9957 | 7.0E-4 | 0 | 2024-06-21 | 27.0 - 31.9 | 0.0 | In |
Call | 2024-06-21 CALL at $20.0 | 0.9855 | 0.0018 | 0 | 2024-06-21 | 24.6 - 29.5 | 0.0 | In |
Call | 2024-06-21 CALL at $22.5 | 0.9841 | 0.0023 | 0 | 2024-06-21 | 22.1 - 27.0 | 0.0 | In |
Call | 2024-06-21 CALL at $25.0 | 0.9604 | 0.0045 | 0 | 2024-06-21 | 20.1 - 24.5 | 0.0 | In |
Call | 2024-06-21 CALL at $30.0 | 0.9193 | 0.0086 | 21 | 2024-06-21 | 15.4 - 20.0 | 19.65 | In |
Call | 2024-06-21 CALL at $35.0 | 0.8584 | 0.0148 | 1 | 2024-06-21 | 11.0 - 15.5 | 24.5 | In |
Call | 2024-06-21 CALL at $40.0 | 0.7501 | 0.0218 | 2 | 2024-06-21 | 7.1 - 12.0 | 29.0 | In |
Call | 2024-06-21 CALL at $45.0 | 0.6163 | 0.0286 | 5 | 2024-06-21 | 4.0 - 8.5 | 22.0 | In |
Call | 2024-06-21 CALL at $50.0 | 0.4659 | 0.0307 | 9 | 2024-06-21 | 1.6 - 6.3 | 6.21 | Out |
Call | 2024-06-21 CALL at $60.0 | 0.1975 | 0.0237 | 112 | 2024-06-21 | 0.0 - 5.0 | 1.15 | Out |
Put | 2024-06-21 PUT at $40.0 | -0.2598 | 0.0204 | 159 | 2024-06-21 | 1.0 - 5.0 | 1.0 | Out |
Put | 2024-06-21 PUT at $45.0 | -0.3846 | 0.0278 | 6 | 2024-06-21 | 2.65 - 6.2 | 3.9 | Out |
Put | 2024-06-21 PUT at $50.0 | -0.5325 | 0.0302 | 18 | 2024-06-21 | 5.1 - 9.3 | 7.05 | In |
Put | 2024-06-21 PUT at $55.0 | -0.6486 | 0.0266 | 8 | 2024-06-21 | 8.7 - 13.0 | 2.72 | In |
Put | 2024-06-21 PUT at $60.0 | -0.7271 | 0.0222 | 205 | 2024-06-21 | 12.5 - 17.0 | 15.17 | In |
Put | 2024-06-21 PUT at $65.0 | -0.8373 | 0.0183 | 2 | 2024-06-21 | 17.1 - 21.0 | 7.9 | In |
Put | 2024-06-21 PUT at $70.0 | -0.8813 | 0.0142 | 0 | 2024-06-21 | 21.5 - 26.0 | 0.0 | In |
Put | 2024-06-21 PUT at $75.0 | -0.9015 | 0.0115 | 3 | 2024-06-21 | 26.8 - 30.5 | 24.0 | In |
Put | 2024-06-21 PUT at $80.0 | -0.918 | 0.0096 | 0 | 2024-06-21 | 31.6 - 35.5 | 0.0 | In |
Put | 2024-06-21 PUT at $85.0 | -0.9283 | 0.0081 | 0 | 2024-06-21 | 36.5 - 40.5 | 0.0 | In |
Put | 2024-06-21 PUT at $90.0 | -0.9433 | 0.0066 | 0 | 2024-06-21 | 41.3 - 45.5 | 0.0 | In |
Put | 2024-06-21 PUT at $95.0 | -0.9343 | 0.0067 | 0 | 2024-06-21 | 46.5 - 50.5 | 0.0 | In |
Put | 2024-06-21 PUT at $100.0 | -0.9363 | 0.0062 | 0 | 2024-06-21 | 51.5 - 55.5 | 0.0 | In |
Put | 2024-06-21 PUT at $105.0 | -0.938 | 0.0058 | 0 | 2024-06-21 | 56.5 - 60.5 | 0.0 | In |
Keros TherapeuticsInc Total Stockholder Equity Over Time
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. Total Stockholder Equity |
| Timeline |
Keros Total Stockholder Equity
Total Stockholder Equity |
|
Be your own money manager
Our tools can tell you how much better you can do entering a position in Keros TherapeuticsInc without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Price Exposure Probability Now
Price Exposure ProbabilityAnalyze equity upside and downside potential for a given time horizon across multiple markets |
| All Next | Launch Module |
Keros TherapeuticsInc Corporate Management
Elected by the shareholders, the Keros TherapeuticsInc's board of directors comprises two types of representatives: Keros TherapeuticsInc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Keros. The board's role is to monitor Keros TherapeuticsInc's management team and ensure that shareholders' interests are well served. Keros TherapeuticsInc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Keros TherapeuticsInc's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Robin Wagner | Senior Resources | Profile | |
| Simon MBBS | Chief Officer | Profile | |
| Keith MBA | Chief Officer | Profile | |
| Christopher MSc | Chief Officer | Profile | |
| John MBA | Senior Management | Profile | |
| Jennifer Lachey | Chief Officer | Profile | |
| Jasbir Seehra | CEO and President | Profile |
Already Invested in Keros TherapeuticsInc?
The danger of trading Keros TherapeuticsInc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Keros TherapeuticsInc is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Keros TherapeuticsInc. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Keros TherapeuticsInc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Keros TherapeuticsInc is a strong investment it is important to analyze Keros TherapeuticsInc's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Keros TherapeuticsInc's future performance. For an informed investment choice regarding Keros Stock, refer to the following important reports: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Keros TherapeuticsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Keros Stock please use our How to Invest in Keros TherapeuticsInc guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Complementary Tools for Keros Stock analysis
When running Keros TherapeuticsInc's price analysis, check to measure Keros TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Keros TherapeuticsInc is operating at the current time. Most of Keros TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Keros TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Keros TherapeuticsInc's price. Additionally, you may evaluate how the addition of Keros TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |
Is Keros TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Keros TherapeuticsInc. If investors know Keros will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Keros TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.15) | Revenue Per Share 0.007 | Return On Assets (0.26) | Return On Equity (0.40) |
The market value of Keros TherapeuticsInc is measured differently than its book value, which is the value of Keros that is recorded on the company's balance sheet. Investors also form their own opinion of Keros TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Keros TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Keros TherapeuticsInc's market value can be influenced by many factors that don't directly affect Keros TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Keros TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Keros TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Keros TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.